Screener
Vir Biotechnology, Inc. VIR Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s asset turnover?
- Vir Biotechnology, Inc. (VIR) reported asset turnover of 0.3× in Q2 2026.
- How has Vir Biotechnology, Inc.'s asset turnover changed year-over-year?
- Vir Biotechnology, Inc.'s asset turnover increased by 1794.0% year-over-year, from 0× to 0.3×.
- What is the long-term trend for Vir Biotechnology, Inc.'s asset turnover?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s asset turnover has grown at a -11.8% compound annual growth rate (CAGR), from 0.1× to 0.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Vir Biotechnology, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude